Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Amaxa

1998 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of a Nucleofector device that that is designed to transfer genes for primary cell research where non-viral gene transfer is required.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • Nattermannallee 1
  • 50829 Cologne
  • Germany

+49 0221 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Amaxa’s full profile, request a free trial.

Amaxa Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jul-2008 000.00 Completed Product Development
2. Early Stage VC 13-Jun-2001 000.00 000.00 Completed Product Development
1. Early Stage VC Completed
To view this company’s complete deal history including valuation and funding, request access »

Amaxa Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3i Group PE/Buyout Minority 000 0000 000000 0
Earlybird Venture Capital Venture Capital Minority 000 0000 000000 0
NRW.Bank Venture Capital Minority 000 0000 000000 0
Technologie-Beteiligungs-Gesellschaft Venture Capital Minority 000 0000 000000 0
Technomedia Kapitalbeteiligungsgesellschaft Koeln Venture Capital Minority 000 0000 000000 0